This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rasmussen, A. K. Articles by Feldt-Rasmussen, U. Search for Related Content PubMed PubMed Citation Articles by Rasmussen, A. K. Articles by Feldt-Rasmussen, U.

The Effects of Interleukin-1ß (IL-1ß) on Human Thyrocyte Functions Are Counteracted by the IL-1 Receptor Antagonist¹

Medical Department P, Endocrine Division (A.K.R., U.F.-R.); the Institute for Inflammation Research, (M.D., K.B.); and the Department of Endocrine Surgery (M.B.-T.), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Address all correspondence and requests for reprints to: Å. Krogh Rasmussen, M.D., Medical Department P2131, Endocrine Division, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark.

The cytokine interleukin-1ß (IL-1ß) is an important regulator of thyroid cell function. IL-1 receptors are present on normal thyrocytes, but the signaling pathway is not fully clarified. As the adenylate cyclase is presumably not activated, we have in the present study investigated whether the cGMP pathway was involved in the actions of IL-1ß, whether the effects of IL-1ß on cultured human thyrocytes were reversible, and whether the effects were counteracted by IL-1 receptor antagonist (IL-1ra), a naturally occurring, specific blocker of IL-1 receptors on many cells. TSH-stimulated cultured human thyroid cells exposed for 72 h to IL-1ß (0.0002–20 µg/liter = 1–10⁵ IU/liter) exhibited a dose-dependent and reversible inhibition of thyroglobulin and cAMP release and a dose-dependent stimulation of cGMP and IL-6 release. These effects were counteracted by coincubation with 250 or 125 µg/liter, but not with 25 and 2.5 µg/liter, IL-1ra. IL-1ra by itself inhibited the release of cAMP, but did not modulate the release of thyroglobulin, cGMP, or IL-6 from the thyrocytes, and IL-1ra was not produced in the extracellular compartment. The nitric oxide generator, sodium nitroprusside, dose dependently generated a TSH-independent release of nitric oxide and cGMP from the thyrocytes. These results indicate that all of the studied effects of IL-1ß on cultured human thyrocytes were exerted through activation of the IL-1 receptor with a signaling pathway involving activation of cGMP and inhibition of cAMP.

This article has been cited by other articles:

				S. Poncin, B. Lengele, I. M. Colin, and A.-C. Gerard Differential Interactions between Th1/Th2, Th1/Th3, and Th2/Th3 Cytokines in the Regulation of Thyroperoxidase and Dual Oxidase Expression, and of Thyroglobulin Secretion in Thyrocytes in Vitro Endocrinology, April 1, 2008; 149(4): 1534 - 1542. [Abstract] [Full Text] [PDF]

				A. D. Flouris, G. S. Metsios, A. Z. Jamurtas, and Y. Koutedakis Sexual dimorphism in the acute effects of secondhand smoke on thyroid hormone secretion, inflammatory markers and vascular function Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E456 - E462. [Abstract] [Full Text] [PDF]

				T. Mühlberg, W. Joba, C. Spitzweg, H.-D. Schworm, H.-J. Heberling, and A. E. Heufelder Interleukin-1 Receptor Antagonist Ribonucleic Acid and Protein Expression by Cultured Graves' and Normal Orbital Fibroblasts Is Differentially Modulated by Dexamethasone and Irradiation J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 734 - 742. [Abstract] [Full Text]

				D. F. Sellitti and S. Q. Doi Regulation of Natriuretic Peptide Receptors by Thyrotropin in FRTL-5 Rat Thyroid Cells: Evidence for Nonguanylate Cyclase Atrial Natriuretic Factor-Binding Sites in Cells Lacking the Natriuretic Peptide Receptor C Endocrinology, March 1, 1999; 140(3): 1365 - 1374. [Abstract] [Full Text]